Glycodelin reduces breast cancer xenograft growthin vivo
نویسندگان
چکیده
منابع مشابه
Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer
Objective(s): P-glycoprotein (P-gp) is an efflux protein, the overexpression of which has been associated with multidrug resistance in various cancers. Although siRNA delivery to reverse P-gp expression may be promising for sensitizing of tumor cells to cytotoxic drugs, the therapeutic use of siRNA requires effective carriers that can deliver siRNA intracellularly with minimal toxicity on targe...
متن کاملSclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo
Background: Sclareol is a phytochemical used in people's diet in Southeast Asia. Objective: To investigate the immunotherapeutic effectiveness of Sclareol against breast cancer by direct intraperitoneal injection. Methods: Sclareol was isolated and purified from Salvia sclarea. Effect of Sclareol on cell growth inhibition was evaluated by MTT assay. Intraperitoneally injected Sclareol effects o...
متن کاملsclareol reduces cd4+ cd25+ foxp3+ t-reg cells in a breast cancer model in vivo
background: sclareol is a phytochemical used in people's diet in southeast asia. objective: to investigate the immunotherapeutic effectiveness of sclareol against breast cancer by direct intraperitoneal injection. methods: sclareol was isolated and purified from salvia sclarea. effect of sclareol on cell growth inhibition was evaluated by mtt assay. intraperitoneally injected sclareol effe...
متن کاملnanolipoparticles-mediated mdr1 sirna delivery reduces doxorubicin resistance in breast cancer cells and silences mdr1 expression in xenograft model of human breast cancer
objective(s): p-glycoprotein (p-gp) is an efflux protein, the overexpression of which has been associated with multidrug resistance in various cancers. although sirna delivery to reverse p-gp expression may be promising for sensitizing of tumor cells to cytotoxic drugs, the therapeutic use of sirna requires effective carriers that can deliver sirna intracellularly with minimal toxicity on targe...
متن کاملDifferential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft
Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge. Understanding subpopulation dynamics is therefore central for both optimization of existing therapy and for development of new treatment. The aim of this study was to isolate subpopulations from a primary tumor and by comparing molecular chara...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Cancer
سال: 2008
ISSN: 0020-7136,1097-0215
DOI: 10.1002/ijc.23773